Product NDC: | 0409-3356 |
Proprietary Name: | Hydromorphone Hydrochloride |
Non Proprietary Name: | HYDROMORPHONE HYDROCHLORIDE |
Active Ingredient(s): | 2 mg/mL & nbsp; HYDROMORPHONE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-3356 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA200403 |
Marketing Category: | NDA |
Start Marketing Date: | 20111201 |
Package NDC: | 0409-3356-01 |
Package Description: | 10 AMPULE in 1 BOX (0409-3356-01) > 1 mL in 1 AMPULE |
NDC Code | 0409-3356-01 |
Proprietary Name | Hydromorphone Hydrochloride |
Package Description | 10 AMPULE in 1 BOX (0409-3356-01) > 1 mL in 1 AMPULE |
Product NDC | 0409-3356 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYDROMORPHONE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20111201 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |